DSI/Habtoor Leighton Specon win $140m Saudi deal
Joint venture picks up MEP work for new $600m King Fahad Medical City
A joint venture between Drake & Scull International and Habtoor Leighton Specon has landed a $140m (SR: 522m) deal to complete MEP works at the National Institute for Neurosciences and the Cancer & Cardiac Centre at the new King Fahad Medical City in Riyadh.
Drake & Scull said that its portion of the deal is worth exactly 50% of the contract, or around $70m (SR: 261m).
The new hospital will be a high-tech facility and will be the first in the region to include a Proton Therapy Cenrte.
The total buit-up area of the hospital will be 234,000m2. It will include an 11-storey building providing the new National Institute of Neurosciences, an 11-storey Comprehensive Cancer Centre and a three-storey Cardiac Centre. There will also be a seven-storey building containing laboratories and offices and a radiology cenrte, cardiology centre, a fou-level central service building and a series of underround car parks and service tunnels.
The overall value of the King Fahad Medical City, which will have a total of 1,095 beds, is $613.3m.
Drake & Scull CEO Khaldoun Tabari said: “The healthcare sector is very important to DSI and we are proud of our historic work in hospital projects around the world.
"The project award is a major milestone in our extensive healthcare experience in the kingdom. Our in-depth knowledge of critical healthcare systems combined with our comprehensive understanding of the specific requirements of the Saudi market make us well suited to undertake projects of similar scale and engineering complexities.
"We see the project award as further consolidation of our status as leaders in the KSA MEP sector. DSI will continue to proactively invest in specialized expertise and cutting-edge technologies to continue to support the development initiatives in KSA and across the region.”